[Clinical pharmacology of trienolones, a group of new anabolically actine aestrane-derivatives (4,9,11-oestratrien-17beta-ol-3-on)].
D015068:17-Ketosteroids / Q000652:urine*; D000293:Adolescent; D000328:Adult; D045930:Anabolic Agents / Q000494:pharmacology*; D001779:Blood Coagulation Factors / Q000032:analysis*; D001798:Blood Proteins / Q000032:analysis*; D002784:Cholesterol / Q000097:blood*; D003864:Depression, Chemical; D004962:Estranes / Q000494:pharmacology*; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009584:Nitrogen / Q000652:urine*; D011516:Prothrombin / Q000032:analysis; D013268:Stimulation, Chemical
D015068:17-Ketosteroids; D045930:Anabolic Agents; D001779:Blood Coagulation Factors; D001798:Blood Proteins; D004962:Estranes; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005170:Factor X; D002784:Cholesterol; D009584:Nitrogen
Klinische Pharmakologie von Trienolonen, einer Gruppe neuartiger anabol wirksamer Oestran-Derivate (4,9,11-Oestratrien-17beta-ol-3-on)